Keywords: medivation/pfizer, initiate, ph, iii, dimebon, trial, world

Medivation/Pfizer initiate Ph III Dimebon trial

Article | 15 April 2009

Print This

World drug giant Pfizer and USA-based Medivation have initiated a 12-month, Phase III trial of Dimebon (dimebolin) when added to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in